EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Human fascioliasis in Egyptian children: successful treatment with triclabendazole


Journal of Tropical Pediatrics 45(3): 135-138
Human fascioliasis in Egyptian children: successful treatment with triclabendazole
During a 2-year period human fascioliasis was diagnosed in 40 Egyptian children. Diagnosis was based on some or all of the following criteria: fever, tender hepatomegaly and high eosinophilia (febrile eosinophilic syndrome), presence of Fasciola hepatica ova in stools, and/or serodiagnosis using the indirect haemagglutination test (IHAT). Eight of the 40 children had failed to respond to previous treatment with praziquantel.


Accession: 003162843

PMID: 10401189

DOI: 10.1093/tropej/45.3.135



Related references

Successful treatment of human fascioliasis with triclabendazole. European Journal of Clinical Microbiology and Infectious Diseases 18(7): 525-526, 1999

The treatment of human fascioliasis with triclabendazole. Revista Clinica Espanola 199(5): 333-335, 1999

Triclabendazole in the treatment of established human fascioliasis. Eastern Mediterranean Health Journal 4(2): 244-251, 1998

Treatment of human fascioliasis with triclabendazole: good news. Transactions of the Royal Society of Tropical Medicine and Hygiene 102(5): 508-508, 2008

Triclabendazole in the treatment of human fascioliasis: a community-based study. Eastern Mediterranean Health Journal 5(5): 888-894, 1999

Triclabendazole in the treatment of human fascioliasis: a community-based study. Eastern Mediterranean Health Journal 5(5): 888-894, 2000

Human fascioliasis with atypical severe presentation. Treatment with triclabendazole. Enfermedades Infecciosas Y Microbiologia Clinica 16(1): 28-30, 1998

Treatment of human fascioliasis with triclabendazole Open study in 22 patients. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 37: 379, 1997

Enzymatic activities in the neutrophils of acute human fascioliasis before and after treatment with triclabendazole. Journal of the Medical Research Institute 17(2): 192-200, 1996

Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. American Journal of Tropical Medicine and Hygiene 52(6): 532-535, 1995